Rhythm

Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women’s Initiative for Heart Recovery

DANVERS, Mass., Feb. 13, 2018 (GLOBE NEWSWIRE) — Abiomed(NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the launch of a new indication and Women’s Initiative focused on heart recovery education and awareness. This Women’s Initiative is in conjunction with the Company’s expanded FDA approval for cardiogenic […]

American College of Cardiology Expands Patient Navigator Program

WASHINGTON, Feb. 8, 2018 /PRNewswire-USNewswire/ — Hundreds of hospitals across the United States will have access to tools and resources to help improve care and lower readmission rates for myocardial infarction (MI) patients as part of the American College of Cardiology’s expanded Patient Navigator Program: Focus MI Quality Campaign. With support from founding sponsor AstraZeneca, […]

ClearFlow Release: Studies Recognizing the Importance of Limiting Retained Blood to Prevent Postoperative Atrial Fibrillation Featured on January Cover of Annals of Thoracic Surgery

Feb. 1, 2018 19:16 UTC –ClearFlow spokespeople cite review article as latest piece of mounting evidence pertaining to urgent need for managing retained blood after surgery– ANAHEIM, Calif.–(BUSINESS WIRE)– ClearFlow, a medical device company based in Anaheim, CA., has announced that the cover of the January 2018 issue of The Annals of […]

HeartSciences Showcases High Sensitivity ECG at 2018 Arab Health Meeting

SOUTHLAKE, Texas–(BUSINESS WIRE)– HeartSciences, an innovative medical device company, is proud to announce its participation as an exhibitor at the upcoming 2018 Arab Health show at the Dubai International Convention and Exhibition Centre in Dubai, UAE, 29 January through 01 February, 2018. HeartSciences is advancing the field of electrocardiology in combining […]

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center First in Texas to Use New Smartphone Compatible, Insertable Cardiac Monitor

AUSTIN, Texas, Jan. 18, 2018 /PRNewswire/ — On Nov. 14, 2017, Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center became the first hospital in Texas—and among the first in the nation—to use the new smartphone compatible Confirm Rx™ Insertable Cardiac Monitor (ICM), the world’s first and only smartphone compatible ICM designed to help physicians […]

CorInnova Wins Top Prize at “RESI San Francisco 2018” Innovation Challenge

HOUSTON–(BUSINESS WIRE)–CorInnova Inc., an emerging medical device company developing breakthrough technology for the treatment of Heart Failure, announced today that it has won First Prize in the “RESI (Redefining Early Stage Investments) San Francisco 2018” investment competition for early-stage life science companies. “We are excited that early-stage investors instantly grasp the […]

iMedrix Announces General Availability of KardioScreen, a CE certified, Connected ECG Device for Universal Use

BANGALORE, January 5, 2018 /PRNewswire/ — iMedrix, a Silicon Valley and Bangalore-based mHealth start-up, announced the general availability of its product KardioScreen, a CE certified mobile/portable hospital grade digital ECG. KardioScreen is the first truly mobile, connected ECG solution that can be applied universally: field screening, point of care, ambulance, Cardiac ICU and […]

First Patient Enrolled in U.S. IDE Study To Evaluate the Potential of New Device To Reduce Stroke Risk in Atrial Fibrillation Patients

IRVINE, Calif., Jan. 11, 2018 /PRNewswire/ — Johnson & Johnson Medical Devices Companies* today announced that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, enrolled the first patient in the WaveCrest® Investigational Device Exemption (IDE) Trial. The study will evaluate the safety and effectiveness of the WaveCrest® Left Atrial […]